MTL President about Private Investments in Science

On 26 September, Anatoly Dabagov, President of MEDICAL TECHNOLOGIES Ltd, took part in a TASS teleconference on private investments in science in Russia and their role in maintaining technological sovereignty.

Mr. Dabagov noted that MTL invests almost all of its profits in R&D, which gives it a leading position in medical technologies. He also stressed the importance of applied science, noting that 95% of the company's developments are successfully brought to market and announced plans to use only domestic key components by 2026.